{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:30:48Z","timestamp":1758400248483,"version":"3.40.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"DOI":"10.7759\/cureus.82530","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T18:06:17Z","timestamp":1744999577000},"source":"Crossref","is-referenced-by-count":1,"title":["Peritoneal Metastasis Mimicking Chemotherapy-Induced Complications in Lung Adenocarcinoma: A Diagnostic Challenge of a Case Report"],"prefix":"10.7759","author":[{"given":"Ryuichi","family":"Ohta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Tanizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst RS","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018, 553:446-54. 10.1038\/nature25183","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi M","year":"2023","unstructured":"Araghi M, Mannani R, Heidarnejad Maleki A, et al.. Recent advances in non-small cell lung cancer targeted therapy; an update review. Cancer Cell Int. 2023, 23:162. 10.1186\/s12935-023-02990-y","journal-title":"Cancer Cell Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031866","article-title":"Peritoneal carcinomatosis secondary to metastatic lung cancer complicated with acute suppurative appendicitis: a case report and literature review","volume":"101","author":"Fu JX","year":"2022","unstructured":"Fu JX, Wang XJ, Xia M, Wang XJ. Peritoneal carcinomatosis secondary to metastatic lung cancer complicated with acute suppurative appendicitis: a case report and literature review. Medicine (Baltimore). 2022, 101:e31866. 10.1097\/MD.0000000000031866","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0469","article-title":"Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review","volume":"15","author":"Abbate MI","year":"2019","unstructured":"Abbate MI, Cortinovis DL, Tiseo M, et al.. Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review. Future Oncol. 2019, 15:989-94. 10.2217\/fon-2018-0469","journal-title":"Future Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-02077-6","article-title":"Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)","volume":"27","author":"Matsusaki K","year":"2022","unstructured":"Matsusaki K, Aridome K, Emoto S, et al.. Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021). Int J Clin Oncol. 2022, 27:1-6. 10.1007\/s10147-021-02077-6","journal-title":"Int J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S40601","article-title":"Presentation and management of docetaxel-related adverse effects in patients with breast cancer","volume":"6","author":"Ho MY","year":"2014","unstructured":"Ho MY, Mackey JR. Presentation and management of docetaxel-related adverse effects in patients with breast cancer. Cancer Manag Res. 2014, 6:253-9. 10.2147\/CMAR.S40601","journal-title":"Cancer Manag Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2016.23.60.8910","article-title":"Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma","volume":"23","author":"Hanane K","year":"2016","unstructured":"Hanane K, Salma B, Khadija B, Ibrahim E, Saber B, Hind M, Hassan E. Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma. Pan Afr Med J. 2016, 23:60. 10.11604\/pamj.2016.23.60.8910","journal-title":"Pan Afr Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10166","article-title":"Non-small cell lung cancer with synchronous peritoneal adenocarcinoma: a rare independent combination","volume":"12","author":"Mandal S","year":"2020","unstructured":"Mandal S, Pradhan RR, Bethala MG, Khan S, Karki A. Non-small cell lung cancer with synchronous peritoneal adenocarcinoma: a rare independent combination. Cureus. 2020, 12:e10166. 10.7759\/cureus.10166","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1176935119837547","article-title":"Development and validation of a nomogram prognostic model for patients with advanced non-small-cell lung cancer","volume":"18","author":"Wang T","year":"2019","unstructured":"Wang T, Lu R, Lai S, et al.. Development and validation of a nomogram prognostic model for patients with advanced non-small-cell lung cancer. Cancer Inform. 2019, 18:1176935119837547. 10.1177\/1176935119837547","journal-title":"Cancer Inform"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2016.03.007","article-title":"Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status","volume":"96","author":"Patil T","year":"2016","unstructured":"Patil T, Aisner DL, Noonan SA, et al.. Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status. Lung Cancer. 2016, 96:27-32. 10.1016\/j.lungcan.2016.03.007","journal-title":"Lung Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-3695","article-title":"Understanding drug sensitivity and tackling resistance in cancer","volume":"82","author":"Tyner JW","year":"2022","unstructured":"Tyner JW, Haderk F, Kumaraswamy A, et al.. Understanding drug sensitivity and tackling resistance in cancer. Cancer Res. 2022, 82:1448-60. 10.1158\/0008-5472.CAN-21-3695","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01955-5","article-title":"Multi-stage mechanisms of tumor metastasis and therapeutic strategies","volume":"9","author":"Liu Z","year":"2024","unstructured":"Liu Z, Chen J, Ren Y, et al.. Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduct Target Ther. 2024, 9:270. 10.1038\/s41392-024-01955-5","journal-title":"Signal Transduct Target Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009742","article-title":"Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events","volume":"12","author":"Shatila M","year":"2024","unstructured":"Shatila M, Zhang HC, Shirwaikar Thomas A, et al.. Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events. J Immunother Cancer. 2024, 12:e009742. 10.1136\/jitc-2024-009742","journal-title":"J Immunother Cancer"},{"key":"ref14","article-title":"Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management","volume":"25","author":"Boussios S","year":"2012","unstructured":"Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N. Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Ann Gastroenterol. 2012, 25:106-18.","journal-title":"Ann Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16480","article-title":"Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy","volume":"8","author":"McMullen JR","year":"2017","unstructured":"McMullen JR, Selleck M, Wall NR, Senthil M. Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget. 2017, 8:43481-90. 10.18632\/oncotarget.16480","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2022.1026","article-title":"Clinical circulating tumor DNA testing for precision oncology","volume":"55","author":"Kim H","year":"2023","unstructured":"Kim H, Park KU. Clinical circulating tumor DNA testing for precision oncology. Cancer Res Treat. 2023, 55:351-66. 10.4143\/crt.2022.1026","journal-title":"Cancer Res Treat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s13691-024-00691-5","article-title":"Ileal perforation at the site of peritoneal metastasis with intestinal infiltration by dual EGFR-VEGF pathway inhibition in an EGFR-mutant non-small cell lung cancer patient","volume":"13","author":"Sanomachi T","year":"2024","unstructured":"Sanomachi T, Yoshida T, Higashiyama RI, Satozono Y, Matsunaga S, Kanemitsu Y, Ohe Y. Ileal perforation at the site of peritoneal metastasis with intestinal infiltration by dual EGFR-VEGF pathway inhibition in an EGFR-mutant non-small cell lung cancer patient. Int Cancer Conf J. 2024, 13:374-6. 10.1007\/s13691-024-00691-5","journal-title":"Int Cancer Conf J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1054","article-title":"Survival benefit of combinatorial osimertinib rechallenge and entrectinib in an EGFR-mutant NSCLC patient with acquired LMNA-NTRK1 fusion following osimertinib resistance","volume":"10","author":"Wang JL","year":"2022","unstructured":"Wang JL, Wang LS, Zhu JQ, Ren J, Wang D, Luo M. Survival benefit of combinatorial osimertinib rechallenge and entrectinib in an EGFR-mutant NSCLC patient with acquired LMNA-NTRK1 fusion following osimertinib resistance. Respirol Case Rep. 2022, 10:e01054. 10.1002\/rcr2.1054","journal-title":"Respirol Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/361664-peritoneal-metastasis-mimicking-chemotherapy-induced-complications-in-lung-adenocarcinoma-a-diagnostic-challenge-of-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T18:06:18Z","timestamp":1744999578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/361664-peritoneal-metastasis-mimicking-chemotherapy-induced-complications-in-lung-adenocarcinoma-a-diagnostic-challenge-of-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.82530","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}